ATX-MS-1467

· Apitope Technology (Bristol) Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ATX-MS-1467, covering 2015-02-16 to 2017-04-13. Get the full timeline:

Most recent: Clinical Trial Update: ATX-MS-1467 in Multiple Sclerosis [Phase 2]